Dr Reddy’s launches Cinacalcet Tablets in US
They are available in 30 mg, 60 mg, and 90 mg tablets in a bottle count size of 30
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Reddy’s Laboratories
Dr Reddy’s launches dimethyl fumarate DR capsules in US
It is a therapeutic equivalent generic version of Tecfidera
Dr Reddy’s launches dexmedetomidine hydrochloride in 0.9% sodium chloride injection in US
It is an alpha-adrenergic agonist indicated for sedation of initially intubated and mechanically ventilated patients during…
Dr Reddy’s announces settlement of Revlimid capsules patent litigation with Celgene in US
Celgene has agreed to provide Dr Reddy’s with a license to sell volume-limited amounts of generic lenalidomide capsules in the US…
Dr Reddy’s launches OTC Olopatadine Hydrochloride Ophthalmic Solution in US
They are indicated for the temporary relief of eye allergies like itchy eyes due to pollen, ragweed, grass, animal hair and dander
RDIF and Dr Reddy’s to partner for trials and supply of 100 mn Sputnik V vaccine doses to India
Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by…
Dr Reddy’s Laboratories launches Diclofenac Sodium Topical Gel in US for arthritis pain relief
The company has partnered with Encube Ethicals to distribute this product in the market
Dr Reddy’s Laboratories launches Redyx (remdesivir) in India
It is available in the strength of 100 mg vial
Dr Reddy’s Laboratories launches Fulvestrant Injection in US
Fulvestrant is an estrogen receptor antagonist indicated for the treatment of HR-positive advanced breast cancer
Dr Reddy’s Labs launch methylphenidate hydrochloride extended-release tablets USP in US
It is indicated for treatment of ADHD in children six years of age and older, adolescents, and adults up to the age of 65